HemoSystem is a blood purification platform with much higher efficiency and precision compared to existing methods. It mixes nanoengineered magnetic beads directly with patients’ blood in a dialysis-like machine where they bind to selected targets.
Hemotune AG has raised €7.1M across 1 funding round from 5 investors, most recently a Series B round in Apr 2022. Based in Zurich, Switzerland; active in Healthtech. Data as of 6 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-04-26 | Series B | €7.1M |
| Hemex,OCCIDENT,Private investor,VP Venture Partners,Zürcher Kantonalbank |
| View deal → |
